J Fortea

532 total citations
21 papers, 396 citations indexed

About

J Fortea is a scholar working on Gastroenterology, Surgery and Physiology. According to data from OpenAlex, J Fortea has authored 21 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Gastroenterology, 7 papers in Surgery and 6 papers in Physiology. Recurrent topics in J Fortea's work include Gastrointestinal motility and disorders (10 papers), Allergic Rhinitis and Sensitization (5 papers) and Asthma and respiratory diseases (5 papers). J Fortea is often cited by papers focused on Gastrointestinal motility and disorders (10 papers), Allergic Rhinitis and Sensitization (5 papers) and Asthma and respiratory diseases (5 papers). J Fortea collaborates with scholars based in Spain, United States and Germany. J Fortea's co-authors include M. Falqués, S. Díaz-Insa, Peter J. Goadsby, G Zanchin, Hartmut Göbel, Nina De Klippel, G Géraud, Nathalie Ivanoff, Jan Tack and Steven J. Shiff and has published in prestigious journals such as Gut, Alimentary Pharmacology & Therapeutics and Cephalalgia.

In The Last Decade

J Fortea

21 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Fortea Spain 9 175 140 139 118 112 21 396
Irene Grazioli Italy 13 147 0.8× 131 0.9× 102 0.7× 88 0.7× 84 0.8× 18 404
Miguel Angelo N. Souza Brazil 11 140 0.8× 126 0.9× 108 0.8× 114 1.0× 430 3.8× 30 711
Hidenori Senba Japan 13 65 0.4× 64 0.5× 16 0.1× 76 0.6× 31 0.3× 43 446
Heiko Pohl Switzerland 9 181 1.0× 38 0.3× 23 0.2× 164 1.4× 95 0.8× 43 387
B Fraitag France 9 14 0.1× 170 1.2× 453 3.3× 289 2.4× 25 0.2× 24 600
Katharine Wilton United Kingdom 11 77 0.4× 56 0.4× 11 0.1× 88 0.7× 64 0.6× 12 537
R Salonen United States 9 371 2.1× 204 1.5× 5 0.0× 34 0.3× 257 2.3× 15 409
María Teresa Goicochea Argentina 11 203 1.2× 71 0.5× 11 0.1× 38 0.3× 149 1.3× 28 307
Johan Bremer Germany 2 15 0.1× 78 0.6× 202 1.5× 67 0.6× 3 0.0× 2 309
Brianna K. Crawley United States 12 14 0.1× 192 1.4× 42 0.3× 97 0.8× 6 0.1× 35 443

Countries citing papers authored by J Fortea

Since Specialization
Citations

This map shows the geographic impact of J Fortea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Fortea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Fortea more than expected).

Fields of papers citing papers by J Fortea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Fortea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Fortea. The network helps show where J Fortea may publish in the future.

Co-authorship network of co-authors of J Fortea

This figure shows the co-authorship network connecting the top 25 collaborators of J Fortea. A scholar is included among the top collaborators of J Fortea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Fortea. J Fortea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yiannakou, Yan, Maria Eugenicos, DS Sanders, et al.. (2015). OC-066 Economic and quality-of-life burden of moderate-to-severe irritable bowel syndrome with constipation (ibs-c) in the uk: the ibis-c study. A33.2–A34. 4 indexed citations
3.
4.
Mearin, Fermín, et al.. (2014). Economic And Quality-Of-Life Burden Of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Spain: The Ibis-C Study. Value in Health. 17(7). A365–A365. 3 indexed citations
5.
Roset, Montse, et al.. (2014). Health Care Cost Associated To Constipation Predominant Irritable Bowel Syndrome In Spain. Value in Health. 17(7). A365–A365. 1 indexed citations
6.
Andresen, Viola, Peter J. Whorwell, J Fortea, & S. Auziere. (2014). An exploration of the barriers to the confident diagnosis of irritable bowel syndrome: A survey among general practitioners, gastroenterologists and experts in five European countries. United European Gastroenterology Journal. 3(1). 39–52. 17 indexed citations
7.
Quigley, Eamonn M.M., Jan Tack, William D. Chey, et al.. (2012). Randomised clinical trials: linaclotide phase 3 studies in IBS ‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints. Alimentary Pharmacology & Therapeutics. 37(1). 49–61. 92 indexed citations
8.
Lembo, Anthony, J Fortea, M. Falqués, et al.. (2012). OC-082 26-Week efficacy and safety of once-daily oral linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a European perspective. Gut. 61(Suppl 2). A35.2–A36. 1 indexed citations
9.
10.
Fortea, J, et al.. (2012). Irritable bowel syndrome with constipation: a European-focused systematic literature review of disease burden. Journal of Medical Economics. 16(3). 329–341. 25 indexed citations
11.
Díaz-Insa, S., Peter J. Goadsby, G Zanchin, et al.. (2011). The Impact of Allodynia on the Efficacy of Almotriptan When Given Early in Migraine: Data From the “Act When Mild” Study. International Journal of Neuroscience. 121(12). 655–661. 18 indexed citations
12.
Fortea, J, et al.. (2008). Ebastine fast-dissolving tablets versus regular tablets: acceptability and preference in patients with allergic rhinitis. Expert Review of Clinical Pharmacology. 1(3). 381–389. 11 indexed citations
13.
Fortea, J, et al.. (2008). Patient assessment of onset of action and overall satisfaction with ebastine fast-dissolving tablets in allergic rhinitis. Expert Review of Pharmacoeconomics & Outcomes Research. 8(4). 337–342. 7 indexed citations
14.
Goadsby, Peter J., G Zanchin, G Géraud, et al.. (2008). Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan. Cephalalgia. 28(4). 383–391. 154 indexed citations
15.
16.
17.
Costa‐Font, Joan, et al.. (2007). Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom. Therapeutics and Clinical Risk Management. 3(2). 225–230. 9 indexed citations
18.
Lamarca, Rosa, et al.. (2006). The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoea. European Journal of Obstetrics & Gynecology and Reproductive Biology. 129(2). 162–168. 20 indexed citations
19.
Fortea, J, et al.. (2005). PAL2 ATTRIBUTES FOR PREFERENCE OF NEW FAST DISSOLVING TABLET (FDT) FORMULATION OF EBASTINE IN PATIENTS WITH ALLERGY. Value in Health. 8(6). A23–A23. 3 indexed citations
20.
Muñoz‐Almagro, Carmen, et al.. (1996). [Microbiological study of the respiratory tract in children with cystic fibrosis].. PubMed. 14(3). 142–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irene Grazioli Breakdown of academic impact, for papers by Miguel Angelo N. Souza Breakdown of academic impact, for papers by Hidenori Senba Breakdown of academic impact, for papers by Heiko Pohl Breakdown of academic impact, for papers by B Fraitag Breakdown of academic impact, for papers by Katharine Wilton Breakdown of academic impact, for papers by R Salonen Breakdown of academic impact, for papers by María Teresa Goicochea Breakdown of academic impact, for papers by Johan Bremer Breakdown of academic impact, for papers by Brianna K. Crawley
Rankless by CCL
2026